AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 72 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | -57.1% | 3,008 | 0.0% | 0.00% | – |
| Q4 2021 | $14,000 | -39.1% | 3,008 | 0.0% | 0.00% | – |
| Q3 2021 | $23,000 | -86.1% | 3,008 | -87.5% | 0.00% | – |
| Q2 2021 | $165,000 | -75.3% | 24,035 | -71.5% | 0.00% | -100.0% |
| Q1 2021 | $668,000 | -39.7% | 84,481 | -40.1% | 0.00% | -50.0% |
| Q4 2020 | $1,108,000 | -5.5% | 141,012 | -14.8% | 0.00% | -33.3% |
| Q3 2020 | $1,172,000 | +94.4% | 165,523 | +153.2% | 0.00% | +200.0% |
| Q2 2020 | $603,000 | +107.9% | 65,361 | +4.6% | 0.00% | 0.0% |
| Q1 2020 | $290,000 | -75.1% | 62,510 | -59.0% | 0.00% | -50.0% |
| Q4 2019 | $1,163,000 | -0.7% | 152,347 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,171,000 | +38933.3% | 152,347 | +37986.8% | 0.00% | – |
| Q2 2019 | $3,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |